Proteases, protease inhibitors and protease-derived peptides: importance in human pathophysiology and therapeutics
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Basel u.a.
Birkhäuser
1993
|
| Schriftenreihe: | Agents and actions / Supplements
42 |
| Schlagworte: | |
| Beschreibung: | 248 S. graph. Darst. |
| ISBN: | 3764328681 0817628681 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV008172952 | ||
| 003 | DE-604 | ||
| 005 | 19930917 | ||
| 007 | t | ||
| 008 | 930817s1993 d||| |||| 00||| eng d | ||
| 020 | |a 3764328681 |9 3-7643-2868-1 | ||
| 020 | |a 0817628681 |9 0-8176-2868-1 | ||
| 035 | |a (OCoLC)27978480 | ||
| 035 | |a (DE-599)BVBBV008172952 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 |a DE-188 | ||
| 050 | 0 | |a QP609.P78 | |
| 082 | 0 | |a 615/.7 |2 20 | |
| 084 | |a YC 7500 |0 (DE-625)153256:12905 |2 rvk | ||
| 084 | |a MED 832f |2 stub | ||
| 084 | |a MED 315f |2 stub | ||
| 084 | |a MED 313f |2 stub | ||
| 245 | 1 | 0 | |a Proteases, protease inhibitors and protease-derived peptides |b importance in human pathophysiology and therapeutics |c ed. by J. C. Cheronis ... |
| 264 | 1 | |a Basel u.a. |b Birkhäuser |c 1993 | |
| 300 | |a 248 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Agents and actions / Supplements |v 42 | |
| 650 | 4 | |a Antiprotéases - Effets physiologiques | |
| 650 | 4 | |a Antiprotéases - Emploi en thérapeutique | |
| 650 | 4 | |a Enzymes protéolytiques - Effets physiologiques | |
| 650 | 4 | |a Enzymes protéolytiques - Physiopathologie | |
| 650 | 7 | |a Inhibitie |2 gtt | |
| 650 | 7 | |a Peptiden |2 gtt | |
| 650 | 7 | |a Proteïnasen |2 gtt | |
| 650 | 4 | |a Endopeptidases |x therapeutic use | |
| 650 | 4 | |a Peptides | |
| 650 | 4 | |a Protease Inhibitors |x therapeutic use | |
| 650 | 4 | |a Protease inhibitors |x Physiological effect | |
| 650 | 4 | |a Protease inhibitors |x Therapeutic use | |
| 650 | 4 | |a Proteolytic enzymes |x Pathophysiology | |
| 650 | 4 | |a Proteolytic enzymes |x Physiological effect | |
| 650 | 0 | 7 | |a Zelldifferenzierung |0 (DE-588)4067536-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Proteaseinhibitor |0 (DE-588)4130450-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Proteasen |0 (DE-588)4047521-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krankheit |0 (DE-588)4032844-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Entzündung |0 (DE-588)4014975-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Heilmittel |0 (DE-588)4024069-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1992 |z Snowmass Colo. |2 gnd-content | |
| 689 | 0 | 0 | |a Proteasen |0 (DE-588)4047521-9 |D s |
| 689 | 0 | 1 | |a Proteaseinhibitor |0 (DE-588)4130450-0 |D s |
| 689 | 0 | 2 | |a Heilmittel |0 (DE-588)4024069-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Krankheit |0 (DE-588)4032844-2 |D s |
| 689 | 1 | 1 | |a Proteasen |0 (DE-588)4047521-9 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Proteaseinhibitor |0 (DE-588)4130450-0 |D s |
| 689 | 2 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Proteasen |0 (DE-588)4047521-9 |D s |
| 689 | 3 | 1 | |a Entzündung |0 (DE-588)4014975-4 |D s |
| 689 | 3 | |5 DE-604 | |
| 689 | 4 | 0 | |a Proteasen |0 (DE-588)4047521-9 |D s |
| 689 | 4 | 1 | |a Zelldifferenzierung |0 (DE-588)4067536-1 |D s |
| 689 | 4 | |5 DE-604 | |
| 700 | 1 | |a Cheronis, John C. |e Sonstige |4 oth | |
| 810 | 2 | |a Supplements |t Agents and actions |v 42 |w (DE-604)BV001899350 |9 42 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-005393191 | |
Datensatz im Suchindex
| _version_ | 1807321954123776000 |
|---|---|
| adam_text | |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV008172952 |
| callnumber-first | Q - Science |
| callnumber-label | QP609 |
| callnumber-raw | QP609.P78 |
| callnumber-search | QP609.P78 |
| callnumber-sort | QP 3609 P78 |
| callnumber-subject | QP - Physiology |
| classification_rvk | YC 7500 |
| classification_tum | MED 832f MED 315f MED 313f |
| ctrlnum | (OCoLC)27978480 (DE-599)BVBBV008172952 |
| dewey-full | 615/.7 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.7 |
| dewey-search | 615/.7 |
| dewey-sort | 3615 17 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV008172952</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19930917</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930817s1993 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3764328681</subfield><subfield code="9">3-7643-2868-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0817628681</subfield><subfield code="9">0-8176-2868-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)27978480</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008172952</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QP609.P78</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.7</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 7500</subfield><subfield code="0">(DE-625)153256:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 832f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 315f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 313f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Proteases, protease inhibitors and protease-derived peptides</subfield><subfield code="b">importance in human pathophysiology and therapeutics</subfield><subfield code="c">ed. by J. C. Cheronis ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel u.a.</subfield><subfield code="b">Birkhäuser</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">248 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Agents and actions / Supplements</subfield><subfield code="v">42</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiprotéases - Effets physiologiques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiprotéases - Emploi en thérapeutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enzymes protéolytiques - Effets physiologiques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enzymes protéolytiques - Physiopathologie</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inhibitie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Peptiden</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Proteïnasen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endopeptidases</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Peptides</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protease Inhibitors</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protease inhibitors</subfield><subfield code="x">Physiological effect</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protease inhibitors</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Proteolytic enzymes</subfield><subfield code="x">Pathophysiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Proteolytic enzymes</subfield><subfield code="x">Physiological effect</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zelldifferenzierung</subfield><subfield code="0">(DE-588)4067536-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteaseinhibitor</subfield><subfield code="0">(DE-588)4130450-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteasen</subfield><subfield code="0">(DE-588)4047521-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krankheit</subfield><subfield code="0">(DE-588)4032844-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Entzündung</subfield><subfield code="0">(DE-588)4014975-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Heilmittel</subfield><subfield code="0">(DE-588)4024069-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1992</subfield><subfield code="z">Snowmass Colo.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Proteasen</subfield><subfield code="0">(DE-588)4047521-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Proteaseinhibitor</subfield><subfield code="0">(DE-588)4130450-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Heilmittel</subfield><subfield code="0">(DE-588)4024069-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krankheit</subfield><subfield code="0">(DE-588)4032844-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Proteasen</subfield><subfield code="0">(DE-588)4047521-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Proteaseinhibitor</subfield><subfield code="0">(DE-588)4130450-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Proteasen</subfield><subfield code="0">(DE-588)4047521-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Entzündung</subfield><subfield code="0">(DE-588)4014975-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Proteasen</subfield><subfield code="0">(DE-588)4047521-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="1"><subfield code="a">Zelldifferenzierung</subfield><subfield code="0">(DE-588)4067536-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cheronis, John C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplements</subfield><subfield code="t">Agents and actions</subfield><subfield code="v">42</subfield><subfield code="w">(DE-604)BV001899350</subfield><subfield code="9">42</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005393191</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1992 Snowmass Colo. gnd-content |
| genre_facet | Konferenzschrift 1992 Snowmass Colo. |
| id | DE-604.BV008172952 |
| illustrated | Illustrated |
| indexdate | 2024-08-14T00:48:49Z |
| institution | BVB |
| isbn | 3764328681 0817628681 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005393191 |
| oclc_num | 27978480 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-188 |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-188 |
| physical | 248 S. graph. Darst. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Birkhäuser |
| record_format | marc |
| series2 | Agents and actions / Supplements |
| spelling | Proteases, protease inhibitors and protease-derived peptides importance in human pathophysiology and therapeutics ed. by J. C. Cheronis ... Basel u.a. Birkhäuser 1993 248 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Agents and actions / Supplements 42 Antiprotéases - Effets physiologiques Antiprotéases - Emploi en thérapeutique Enzymes protéolytiques - Effets physiologiques Enzymes protéolytiques - Physiopathologie Inhibitie gtt Peptiden gtt Proteïnasen gtt Endopeptidases therapeutic use Peptides Protease Inhibitors therapeutic use Protease inhibitors Physiological effect Protease inhibitors Therapeutic use Proteolytic enzymes Pathophysiology Proteolytic enzymes Physiological effect Zelldifferenzierung (DE-588)4067536-1 gnd rswk-swf Proteaseinhibitor (DE-588)4130450-0 gnd rswk-swf Proteasen (DE-588)4047521-9 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Krankheit (DE-588)4032844-2 gnd rswk-swf Entzündung (DE-588)4014975-4 gnd rswk-swf Heilmittel (DE-588)4024069-1 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1992 Snowmass Colo. gnd-content Proteasen (DE-588)4047521-9 s Proteaseinhibitor (DE-588)4130450-0 s Heilmittel (DE-588)4024069-1 s DE-604 Krankheit (DE-588)4032844-2 s Pharmakotherapie (DE-588)4076066-2 s Entzündung (DE-588)4014975-4 s Zelldifferenzierung (DE-588)4067536-1 s Cheronis, John C. Sonstige oth Supplements Agents and actions 42 (DE-604)BV001899350 42 |
| spellingShingle | Proteases, protease inhibitors and protease-derived peptides importance in human pathophysiology and therapeutics Antiprotéases - Effets physiologiques Antiprotéases - Emploi en thérapeutique Enzymes protéolytiques - Effets physiologiques Enzymes protéolytiques - Physiopathologie Inhibitie gtt Peptiden gtt Proteïnasen gtt Endopeptidases therapeutic use Peptides Protease Inhibitors therapeutic use Protease inhibitors Physiological effect Protease inhibitors Therapeutic use Proteolytic enzymes Pathophysiology Proteolytic enzymes Physiological effect Zelldifferenzierung (DE-588)4067536-1 gnd Proteaseinhibitor (DE-588)4130450-0 gnd Proteasen (DE-588)4047521-9 gnd Pharmakotherapie (DE-588)4076066-2 gnd Krankheit (DE-588)4032844-2 gnd Entzündung (DE-588)4014975-4 gnd Heilmittel (DE-588)4024069-1 gnd |
| subject_GND | (DE-588)4067536-1 (DE-588)4130450-0 (DE-588)4047521-9 (DE-588)4076066-2 (DE-588)4032844-2 (DE-588)4014975-4 (DE-588)4024069-1 (DE-588)1071861417 |
| title | Proteases, protease inhibitors and protease-derived peptides importance in human pathophysiology and therapeutics |
| title_auth | Proteases, protease inhibitors and protease-derived peptides importance in human pathophysiology and therapeutics |
| title_exact_search | Proteases, protease inhibitors and protease-derived peptides importance in human pathophysiology and therapeutics |
| title_full | Proteases, protease inhibitors and protease-derived peptides importance in human pathophysiology and therapeutics ed. by J. C. Cheronis ... |
| title_fullStr | Proteases, protease inhibitors and protease-derived peptides importance in human pathophysiology and therapeutics ed. by J. C. Cheronis ... |
| title_full_unstemmed | Proteases, protease inhibitors and protease-derived peptides importance in human pathophysiology and therapeutics ed. by J. C. Cheronis ... |
| title_short | Proteases, protease inhibitors and protease-derived peptides |
| title_sort | proteases protease inhibitors and protease derived peptides importance in human pathophysiology and therapeutics |
| title_sub | importance in human pathophysiology and therapeutics |
| topic | Antiprotéases - Effets physiologiques Antiprotéases - Emploi en thérapeutique Enzymes protéolytiques - Effets physiologiques Enzymes protéolytiques - Physiopathologie Inhibitie gtt Peptiden gtt Proteïnasen gtt Endopeptidases therapeutic use Peptides Protease Inhibitors therapeutic use Protease inhibitors Physiological effect Protease inhibitors Therapeutic use Proteolytic enzymes Pathophysiology Proteolytic enzymes Physiological effect Zelldifferenzierung (DE-588)4067536-1 gnd Proteaseinhibitor (DE-588)4130450-0 gnd Proteasen (DE-588)4047521-9 gnd Pharmakotherapie (DE-588)4076066-2 gnd Krankheit (DE-588)4032844-2 gnd Entzündung (DE-588)4014975-4 gnd Heilmittel (DE-588)4024069-1 gnd |
| topic_facet | Antiprotéases - Effets physiologiques Antiprotéases - Emploi en thérapeutique Enzymes protéolytiques - Effets physiologiques Enzymes protéolytiques - Physiopathologie Inhibitie Peptiden Proteïnasen Endopeptidases therapeutic use Peptides Protease Inhibitors therapeutic use Protease inhibitors Physiological effect Protease inhibitors Therapeutic use Proteolytic enzymes Pathophysiology Proteolytic enzymes Physiological effect Zelldifferenzierung Proteaseinhibitor Proteasen Pharmakotherapie Krankheit Entzündung Heilmittel Konferenzschrift 1992 Snowmass Colo. |
| volume_link | (DE-604)BV001899350 |
| work_keys_str_mv | AT cheronisjohnc proteasesproteaseinhibitorsandproteasederivedpeptidesimportanceinhumanpathophysiologyandtherapeutics |